Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Iatrogenic effects of biologics for psoriasis
Mary L. Stevenson
,
Mark Lebwohl
Icahn School of Medicine at Mount Sinai
Waldman Department of Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Iatrogenic effects of biologics for psoriasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Biological Agents
100%
Psoriasis
100%
Iatrogenic Effects
100%
T Cells
50%
Treatment Options
50%
Moderate to Severe
50%
Traditional Agents
50%
Chronic Plaque Psoriasis
50%
Anti-tumor Necrosis Factor Agents
50%
Interleukin-1 Inhibitors
50%
Medicine and Dentistry
Biological Product
100%
Psoriasis
100%
Cytokine
50%
T Cell
50%
Necrosis
50%
Psoriasis Vulgaris
50%
Treatment Option
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Product
100%
Psoriasis
100%
Cytokine
50%
Psoriasis Vulgaris
50%
Necrosis
50%
Nursing and Health Professions
Biological Product
100%
Psoriasis
100%
Psoriasis Vulgaris
50%
Necrosis
50%